| Dr Parth Maheshwari, DMD | |
|
6535 N Palm Ave Ste 102, Fresno, CA 93704-1064 | |
| (559) 435-3200 | |
| Not Available |
| Full Name | Dr Parth Maheshwari |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 6535 N Palm Ave Ste 102, Fresno, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235802315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 106710 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Parth Maheshwari, DMD 6535 N Palm Ave Ste 102, Fresno, CA 93704-1064 Ph: (559) 435-3200 | Dr Parth Maheshwari, DMD 6535 N Palm Ave Ste 102, Fresno, CA 93704-1064 Ph: (559) 435-3200 |
News Archive
Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profile of men who have a PSA level at or below what is considered 'normal.' New research published in the latest edition of Archives of Internal Medicine (Vol. 170, No. 14) by a team of investigators at The Cancer Institute of New Jersey (CINJ), further explores this population. The findings show that most men with prostate cancer who tested below the normal PSA level and had low-risk disease nevertheless underwent aggressive treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
By identifying novel genes critical to cancer progression, biologists at the U.S. Department of Energy's Argonne National Laboratory have expanded the number of drug targets researchers have available for study to find ways to stop tumors in their tracks.
Bracket Global, LLC and Clintara are pleased to announce the two companies have agreed to combine. Bracket will integrate the Clintara platform of surveillance strategies developed for clinical trials within Bracket's proprietary electronic platform for Clinical Outcome Assessments (eCOA).
As a member of the S100 family, S100A2 is considered a candidate tumor-suppressor gene. Recently, p63 gene, a new member of the p53 gene family, has been studied in the fields of tumorigenesis, cell apoptosis and tissue growth. At present, few studies have been carried out on the expression and relationship of S100A2 and p63 in EC.
› Verified 2 days ago
Rahul Deepak Golani, BDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4646 N 1st St, Fresno, CA 93726 Phone: 800-300-6664 | |
Dr. Gregory Miyake, DDS Dentist Medicare: Medicare Enrolled Practice Location: 7234 N Sequoia Ave, Fresno, CA 93711 Phone: 559-246-4195 Fax: 559-447-1813 | |
Dr. Albert Pomerantz, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4820 N 1st St Ste 101, Fresno, CA 93726 Phone: 559-226-6681 Fax: 559-226-6806 | |
Mr. Paramjit S Sandhu, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2509 E Cole Ave, Fresno, CA 93720 Phone: 559-323-7120 | |
Dr. Quincy Izabela Sofowora, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4901 E Kings Canyon Rd, Fresno, CA 93727 Phone: 866-592-8129 | |
Saadia A Rana, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6687 N Blackstone Ave Ste 101, Fresno, CA 93710 Phone: 559-439-5231 | |
Dr. Aye K. Ko, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1409 N Fresno St, Fresno, CA 93703 Phone: 559-264-4543 Fax: 559-264-0226 |